Page last updated: 2024-08-18

isomethyleugenol and Orbital Neoplasms

isomethyleugenol has been researched along with Orbital Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Birnbaum, R; Gur, H; Kidron, D; Lerman-Sagie, T; Lev, D; Malinger, G; Yanoov-Sharav, M; Yosha-Orpaz, N; Yosovich, K1
Chan, DD; Chan, WM; Choi, PC; Choy, KW; Lam, DS; Liu, DT; Pang, CP; To, KF; Wong, CY1

Other Studies

2 other study(ies) available for isomethyleugenol and Orbital Neoplasms

ArticleYear
Prenatal and postnatal presentation of PRMT7 related syndrome: Expanding the phenotypic manifestations.
    American journal of medical genetics. Part A, 2019, Volume: 179, Issue:1

    Topics: Arginine; Astrocytoma; Brachydactyly; Developmental Disabilities; Female; Fetal Growth Retardation; Humans; Infant; Infant, Newborn; Intellectual Disability; Male; Methylation; Muscle Hypotonia; Mutation; Orbital Neoplasms; Pregnancy; Protein-Arginine N-Methyltransferases

2019
Pediatric malignancies. Case 1. Hypermethylation in orbital alveolar rhabdomyosarcoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jul-20, Volume: 23, Issue:21

    Topics: Humans; Infant; Male; Methylation; Orbital Neoplasms; Rhabdomyosarcoma, Alveolar

2005